PATH in the United Kingdom (PATHFINDER)

Last updated date

11:34am

Collaboration with University College London to integrate PATH into the National Health Service

Investigators: Robert Howard, Rebecca Gould, Liz Cort

This study focuses on implementing PATHFINDER. It is funded by the National Institute for Health Research – Health Technology Assessment of the UK. It is a version of PATH adapted for people with mild to moderate dementia in the UK. Patients are randomly assigned to either PATH therapy or usual care. They receive 8 weeks of PATH therapy, the first two sessions are at the patient’s home.

Weill Cornell Medicine Kiosses Lab 21 Bloomingdale Road, Unit 7 South White Plains, NY 10605 Phone: (914) 682-9100 ext. 101-2570